Firstly, CAFs could facilitate HCC cells epithelial-to-mesenchymal transition (EMT) through the transglutaminase 2-dependent IL-6/IL6R/STAT3 pathway, and promote HCC metastasis by activating HIF1α/ZEB1 axis (42–44). Here, HIF1A is linked to hepatocellular carcinoma.